Literature DB >> 2542594

Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors.

Y Li1, L Z Luo, R R Wagner.   

Abstract

The matrix (M) protein of vesicular stomatitis virus serves as an endogenous inhibitor of viral transcription, a function missing or deficient in M proteins of temperature-sensitive (ts) mutants assigned to complementation group III. Previous studies with mutant tsO23(III) and vaccinia virus M-gene expression vectors revealed that the temperature-sensitive phenotype is due to a mutation leading to substitution of phenylalanine for leucine at amino acid III, whereas loss of the major antigenic determinant (epitope 1) of the mutant M protein results from the substitution of glutamic acid for the wild-type amino acid glycine at position 21 (Y. Li, L. Luo, R. M. Snyder, and R. R. Wagner, J. Virol. 62:3729-3737, 1988). We demonstrate here that transcription inhibition activity is restored to rescued tsO23 virus only when the rescuing vaccinia virus recombinant expresses M protein with glycine and not glutamic acid at amino acid 21. These experiments indicate the importance of the conformational integrity of the amino-terminal domain in determining the capacity of the vesicular stomatitis virus M protein to down regulate endogenous transcription.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542594      PMCID: PMC250793     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

1.  Noninfectious vesicular stomatitis virus particles deficient in the viral nucleocapsid.

Authors:  T J Schnitzer; H F Lodish
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses.

Authors:  R A Weiss; P L Bennett
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

5.  Phenotypic revertants of temperature-sensitive M protein mutants of vesicular stomatitis virus: sequence analysis and functional characterization.

Authors:  K Morita; R Vanderoef; J Lenard
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

6.  The matrix (M) protein of vesicular stomatitis virus regulates transcription.

Authors:  G M Clinton; S P Little; F S Hagen; A S Huang
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

8.  Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies.

Authors:  J R Ogden; R Pal; R R Wagner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

10.  Interaction of wild-type and mutant M protein vesicular stomatitis virus with nucleocapsids in vitro.

Authors:  T Wilson; J Lenard
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

View more
  7 in total

1.  Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids.

Authors:  P E Kaptur; R B Rhodes; D S Lyles
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis.

Authors:  Geneviève Mottet-Osman; Frédéric Iseni; Thierry Pelet; Maciej Wiznerowicz; Dominique Garcin; Laurent Roux
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

3.  Comparative sequence analysis of the M gene among rabies virus strains and its expression by recombinant vaccinia virus.

Authors:  K Hiramatsu; K Mannen; K Mifune; A Nishizono; Y Takita-Sonoda
Journal:  Virus Genes       Date:  1993-02       Impact factor: 2.332

4.  Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.

Authors:  P A Justice; W Sun; Y Li; Z Ye; P R Grigera; R R Wagner
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.

Authors:  L A Ball; C R Pringle; B Flanagan; V P Perepelitsa; G W Wertz
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus.

Authors:  Z Ye; W Sun; K Suryanarayana; P Justice; D Robinson; R R Wagner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.

Authors:  S Y Paik; A C Banerjea; G G Harmison; C J Chen; M Schubert
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.